Lee, Byung Chan
Kim, Kyung Il
Cho, Kang Hee
Moon, Chang-Won
Funding for this research was provided by:
Korea Health Technology R&D project (HR22C1734)
Article History
Received: 16 March 2023
Accepted: 3 January 2024
First Online: 17 January 2024
Declarations
:
: The ethical validity of the trial was assessed and approved by the Institutional Review Board of Chungnam National University Hospital (CNUH 2022-12-026). In accordance with the Declaration of Helsinki and its subsequent amendments, every patient had the right to leave the study at any time, for any reason, without having to give explanations and without repercussions on his or her aftercare. Likewise, the investigating physician had the right to withdraw a patient from a study when he/she believed it was in the patient's best interest. All participants will provide written informed consent before the trial.This work has not been previously presented or published in any form or any language.
: Not applicable.
: Dr. CW Moon is receiving financial support from a Korea Health Technology R&D project for their work in this study, through the Korea Health Industry Development Institute (KHIDI) funded by the Ministry of Health & Welfare, Republic of Korea. BC Lee, KI Kim, and KH Cho declares no conflicts of interest.